Postoperative treatment with Vitamin D for patients with a history of Bariatric Surgery in C and U County.

Postoperative treatment with Vitamin D for patients with a history of Bariatric Surgery in C and U County. - SOL

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-002217-19-SE

Enrollment

220

Registered

2012-09-27

Start date

2012-12-13

Completion date

Unknown

Last updated

2013-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypovitaminosis D after bariatric surgery

Interventions

Trade Name: Vitamin D3 Streuli Product Name: Vitamin D3 Streuli Pharmaceutical Form: Injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gastric bypass or duodenal switch performed in 2008-2011 at Akademiska hospital in Uppsala. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 220 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Medication that influences calciumhomeostasis. Planned vacation in a sunny country during the study period or use of cosmetic solarium.

Design outcomes

Primary

Measure	Time frame
Main Objective: To study the effect on vitamin D levels after bariatric surgery by administrating an injection of cholecalciferol at one occasion, compared to no treatment at all.;Secondary Objective: not applicable;Primary end point(s): Difference in vitamin D level before and three and six months after administration of cholecalciferol.;Timepoint(s) of evaluation of this end point: Three and six months post injection.	—

Measure

Time frame

Main Objective: To study the effect on vitamin D levels after bariatric surgery by administrating an injection of cholecalciferol at one occasion, compared to no treatment at all.;Secondary Objective: not applicable;Primary end point(s): Difference in vitamin D level before and three and six months after administration of cholecalciferol.;Timepoint(s) of evaluation of this end point: Three and six months post injection.

—

Secondary

Measure	Time frame
Secondary end point(s): Not applicable;Timepoint(s) of evaluation of this end point: not applicable	—

Countries

Sweden

Contacts

Public ContactKirurgmottagningen

Department of Surgery

hella.hultin@surgsci.uu.se+46186110000

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026